Endotoxin testing
/EN-do-TOX-in/
Also known as: bacterial endotoxin, lipopolysaccharide, LPS, pyrogen, LAL test
Definition
Endotoxin testing is a critical quality control measure for injectable pharmaceutical products and biological compounds, including peptides. Endotoxins are lipopolysaccharides (LPS) derived from the outer membrane of gram-negative bacteria. Even in minute quantities, endotoxins can provoke strong fever responses (pyrogenic reactions) and systemic inflammatory reactions when introduced into the bloodstream or other body compartments. The standard method for endotoxin detection is the Limulus Amebocyte Lysate (LAL) test, which uses a reagent extracted from horseshoe crab blood that reacts to endotoxins with a color change or other detectable signal. Acceptable endotoxin levels are measured in endotoxin units (EU) per dose or per mL, with regulatory limits varying by product type and route of administration. For research peptides intended for injection or use in research involving animal models or human subjects, endotoxin testing confirms that the preparation is free from pyrogen contamination that could confound results or cause adverse reactions.
Endotoxin contamination can arise during manufacturing, packaging, or storage if proper sanitation and aseptic technique are not maintained. Gram-negative bacteria such as Escherichia coli and Pseudomonas aeruginosa are common environmental contaminants. The LAL test is sensitive enough to detect endotoxins at concentrations of a fraction of an EU/mL, making it suitable for release testing of pharmaceutical products. The test is incorporated into official pharmacopeias (such as the European Pharmacopoeia and the United States Pharmacopeia) as a standard requirement for injectable products.
For research applications, endotoxin contamination is problematic because endotoxins themselves produce biological effects (fever, inflammation, immune activation) that can confound research results and mask or mimic the effects of the peptide compound being studied. Researchers must ensure that reagents, vehicles, and the peptide compound itself are endotoxin-free when conducting studies in which immune responses, inflammatory markers, or fever could confound interpretation. High-quality peptide suppliers test for endotoxins and report results in the Certificate of Analysis, ensuring that the product is suitable for sensitive research applications.